Where I see patients (1)
My reviews
Selected research
-
Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma.
Blood advances
-
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
-
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.
Blood cancer journal
Clinical trials
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
4.8